Xtl Biopharmaceuticals (XTLB) Intangibles (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) reported Intangibles of $3.82 million for the quarter ended Dec 31, 2024, up 904.2% from $380,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Intangibles (2010 - 2024) Analysis & Trends
Dating back to the quarter ended Sep 30, 2010, Xtl Biopharmaceuticals' Intangibles record includes 40 quarters.
- Intangibles has a five-year compound annual growth rate of 58.6% (years ended Dec 2019 to Dec 2024).
- By year, Intangibles came in at $380,000 in the year ended Dec 31, 2023 (unchanged), $380,000 in the year ended Dec 31, 2022 (unchanged), $380,000 in the year ended Dec 31, 2021 (unchanged) and $380,000 in the year ended Dec 31, 2020 (unchanged).
- The figure for the quarter ended Dec 31, 2024 ranks as the highest quarterly Intangibles since the quarter ended Sep 30, 2013.
- Year over year, Intangibles gained in 1 of the last six quarters, with growth averaging 150.7%.
- The year-over-year growth in Intangibles has ranged between 0.0% (the quarter ended Dec 31, 2020) and 904.2% (the quarter ended Dec 31, 2024) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Xtl Biopharmaceuticals | 16.76 Mn | 13.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 3.82 Mn |
| Jun 30, 2024 | 380,000.00 |
| Mar 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Sep 30, 2023 | 380,000.00 |
| Jun 30, 2023 | 380,000.00 |
| Mar 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 380,000.00 |
| Sep 30, 2022 | 380,000.00 |
| Jun 30, 2022 | 380,000.00 |
| Dec 31, 2021 | 380,000.00 |
| Jun 30, 2021 | 380,000.00 |
| Dec 31, 2020 | 380,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Dec 31, 2018 | 380,000.00 |
| Sep 30, 2018 | 380,000.00 |
| Dec 31, 2017 | 380,000.00 |
| Dec 31, 2016 | 253,000.00 |
| Jun 30, 2016 | 1.10 Mn |
| Dec 31, 2015 | 1.04 Mn |
API Access
Xtl Biopharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();